PET pharmacokinetic modelling

NATO Science for Peace and Security Series B: Physics and Biophysics

Volumn , Issue , 2008, Pages 189-210

  Müller Schauenburg, Wolfgang ^a   Reimold, Matthias ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Modelling; PET; Pharmacokinetics; Positron emission tomography; Receptors

Indexed keywords

EID: 77949346023     PISSN: 18746500     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4020-8752-3_11     Document Type: Article

References (19)

1. Maguire, R.P., Leenders, K.L., Eds, 2007, PET Pharmacokinetic Course Manual 2007, Osaka, Japan.
2. Renkin E.M., 1959, Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am. J. Physiol., 197:1205-1210.
3. Crone, C., 1964, The permeability of capillaries in various organs as determined by use of the indicator diffusion method. Acta Physiol. Scand., 58:292-305.
4. James, F., Roos, M., 1976, Minuit. A System for Function Minimization and Analysis of the Parameter Errors and Correlations, CERN, Geneva.
5. Nelder, J.A., Mead, R., 1965, A simplex method for function minimization. Comput. J., 7:308-313.
6. Levenberg, K., 1944, A Method for the solution of certain problems in least squares. Quart. Appl. Math., 2:164-168.
7. Marquardt, D.W., 1963, An algorithm for least-squares estimation of nonlinear parameters. J. Soc. Indust. Appl. Math., 11:431-441.
8. Mintun, M.A., Raichle, M.E., et al., 1984, A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Annals of Neurology, 15(3):217-227.
9. Innis, B.I., Cunningham, V.C., Delforge, J., et al., 2007, Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. advance online publication, 9 May 2007, 27:1533-1539; doi:10.1038/sj.jcbfm.9600493.
10. 11C]WAY-100635 in humans: comparison of arterial and reference tissue input functions. J. Cereb. Blood Flow Metab., 20:1111-1133.
11. Lammertsma, A.A., Bench, C.J., Hume, S.P., 1996, Comparison of methods for analysis of clinical [11C]raclopride studies. J. Cereb. Blood Flow Metab., 16:42-52.
12. Lammertsma, A.A., Hume, S.P., 1996, Simplified reference tissue model for PET receptor studies. NeuroImage, 4:153-158.
13. Hume, S.P. et al., 1992, Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 12: 47-54.
14. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J. Cereb. Blood Flow Metab., 23: 1096-1111.
15. Delforge, J., Syrota, A., Bottlaender, M., et al., 1993, Modelling analysis of [11C]flumazenil kinetics studied by PET: application to a critical study of the equilibrium approaches. J. Cereb. Blood Flow Metab, 13(3):454-468.
16. 11C]flumazenil, and a single-experiment protocol. J. Cereb. Blood Flow Metab., 15:284-300.
17. Laruelle, M., Slifstein, M., Huang, Y., 2002, Positron emission tomography: imaging and quantification of neurotransporter availability. Methods, 27(3): 287-299.
18. Patlak, C.S., Blasberg, R.G., Fenstermacher, J.D., 1983, Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab., 3:1-7.
19. Reimold, M., Feb 22, 2007, Binding Potential, http://en.wikipedia.org/ wiki/Bindingpotential